Erdheim-Chester Disease Clinical Trials

17 clinical trials for Erdheim-Chester Disease across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Histiocytic Disorder Follow-up Study — RECRUITING
• ECD-Score: a Study on Erdheim-Chester Disease — RECRUITING
• In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET — RECRUITING · PHASE1
• Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses — RECRUITING
• DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. — RECRUITING · PHASE2
• Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders — RECRUITING · PHASE2
• International Rare Histiocytic Disorders Registry (IRHDR) — RECRUITING
• Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease — TERMINATED · PHASE1
• DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. — NOT_YET_RECRUITING · PHASE2
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors — TERMINATED · PHASE1
• GWAS and EWAS in Patients With Erdheim-Chester Disease — OTHER
• Subtypes and Prognostic Factors in Erdheim-Chester Disease — OTHER · NA
• The Efficacy and Safety of HLX208 in Adult Langerhans Cell Histiocytosis (LCH) and Erdheim-Chester Disease (ECD) With BRAF V600E Mutation — OTHER · PHASE2
• Dabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 Mutations — WITHDRAWN · PHASE2
• Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement — COMPLETED
• Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease — OTHER
• Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease — TERMINATED · PHASE2

Refine this search